Artal Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-157,000
| Closed | -$1.04M | – | 135 |
|
|
2022
Q3 | $1.04M | Sell |
157,000
-843,000
| -84% | -$5.61M | 0.04% | 108 |
|
|
2022
Q2 | $4.84M | Hold |
1,000,000
| – | – | 0.26% | 58 |
|
|
2022
Q1 | $9.35M | Hold |
1,000,000
| – | – | 0.39% | 48 |
|
|
2021
Q4 | $11.9M | Hold |
1,000,000
| – | – | 0.32% | 60 |
|
|
2021
Q3 | $11.4M | Hold |
1,000,000
| – | – | 0.25% | 70 |
|
|
2021
Q2 | $17.9M | Buy |
1,000,000
+200,000
| +25% | +$3.59M | 0.36% | 53 |
|
|
2021
Q1 | $12.4M | Buy |
800,000
+500,000
| +167% | +$7.74M | 0.22% | 79 |
|
|
2020
Q4 | $3.66M | Buy |
+300,000
| New | +$3.66M | 0.08% | 106 |
|
|
2019
Q1 | – | Sell |
-125,000
| Closed | -$1.44M | – | 109 |
|
|
2018
Q4 | $1.44M | Hold |
125,000
| – | – | 0.05% | 74 |
|
|
2018
Q3 | $5M | Hold |
125,000
| – | – | 0.13% | 55 |
|
|
2018
Q2 | $3.54M | Hold |
125,000
| – | – | 0.08% | 59 |
|
|
2018
Q1 | $1.91M | Buy |
125,000
+75,000
| +150% | +$1.15M | 0.02% | 66 |
|
|
2017
Q4 | $1.63M | Buy |
+50,000
| New | +$1.63M | 0.02% | 65 |
|